Candriam SCA’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Candriam SCA’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-360,789	Closed	-$12M	–	716
2024 Q3	$12M	Buy	360,789 +134,872	+60%	+$4.64M	0.07%	247
2024 Q2	$6.11M	Buy	+225,917	New	+$4.46M	0.04%	312

Candriam SCA's LBPH Position: Q4 2024 in Review

Candriam SCA sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 360,789 shares — an estimated $12M sold.

Candriam SCA first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $12M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Candriam SCA reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Candriam SCA sold 360,789 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $12M.
Candriam SCA first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Candriam SCA's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $12M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Candriam SCA's 13F filing for Q4 2024, filed 7 Feb 2025.